A single-armed exploratory clinical research of S1/ oxaliplatin chemotherapy plus Apatinib in the conversion therapy of metastatic gastric cancer.

Trial Profile

A single-armed exploratory clinical research of S1/ oxaliplatin chemotherapy plus Apatinib in the conversion therapy of metastatic gastric cancer.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Apatinib (Primary) ; Gimeracil/oteracil/tegafur; Oxaliplatin
  • Indications Adenocarcinoma; Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top